Ve Wong Corporation AI Stock Analysis
Ve Wong Corporation (1203) AI Stock Analysis
Ve Wong Corporation
(TWSE:1203)
The score is primarily supported by a strong balance sheet, low leverage, and healthy cash generation. Declining 2025 operating performance, mixed technical signals, and only moderate valuation support limit the overall score.
Ve Wong Corporation (1203) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 10.17B
- Dividend Yield
- 2.27%
- Average Volume (3M)
- 22.32K
- Price to Earnings (P/E)
- 21.1
- Beta (1Y)
- 0.12
- Revenue Growth
- -13.42%
- EPS Growth
- 12.83%
- Country
- TW
- Employees
- 1,778
- Sector
- General
- Sector Strength
- 55
- Industry
- Packaged Foods
Ve Wong Corporation Business Overview & Revenue Model
Company Description
Ve Wong Corporation operates as a producer and distributor of various food items, beverages, and flavorings across Taiwan, Thailand, and Vietnam. The company's diverse product portfolio features essentials like instant noodles and soups, monosodium g...
Ve Wong Corporation Financial Statement Overview
Summary
Financially stable overall: the strong balance sheet scored 87 and healthy cash generation scored 78, offset by declining revenue, net income, margins, and a 62 income-statement score.
Income Statement
62PositiveBalance Sheet
87Very PositiveCash Flow
78Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.33B | 5.65B | 6.29B | 6.40B | 6.39B | 5.82B |
| Gross Profit | 1.79B | 1.96B | 2.12B | 1.87B | 1.83B | 1.90B |
| EBITDA | 1.10B | 1.16B | 1.38B | 1.08B | 1.28B | 1.07B |
| Net Income | 498.63M | 430.56M | 561.04M | 427.70M | 625.40M | 447.88M |
Balance Sheet | ||||||
| Total Assets | 10.71B | 10.49B | 10.28B | 10.11B | 10.00B | 9.58B |
| Cash, Cash Equivalents and Short-Term Investments | 2.70B | 2.97B | 2.36B | 2.29B | 2.07B | 2.52B |
| Total Debt | 932.75M | 1.08B | 995.49M | 1.10B | 1.10B | 1.04B |
| Total Liabilities | 3.36B | 3.06B | 3.07B | 3.35B | 3.43B | 3.33B |
| Stockholders Equity | 6.50B | 6.38B | 6.18B | 5.77B | 5.53B | 5.27B |
Cash Flow | ||||||
| Free Cash Flow | 1.01B | 1.18B | 667.30M | 1.02B | -68.74M | 853.28M |
| Operating Cash Flow | 1.10B | 1.26B | 796.60M | 1.31B | 184.91M | 965.07M |
| Investing Cash Flow | -229.70M | -328.01M | -55.79M | -389.47M | -188.36M | -323.52M |
| Financing Cash Flow | -521.13M | -535.93M | -700.90M | -587.87M | -440.00M | -426.93M |
Ve Wong Corporation Peers Comparison
Overall Rating
TW:170773Outperform
TW:126470Outperform
TW:120370Outperform
TW:843662Neutral
TW:646956Neutral
TW:290844Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | TWD 11.75B | 11.04 | ― | 7.57% | -5.38% | -12.85% | |
| 70Outperform | TWD 8.93B | 10.91 | ― | 6.22% | 3.48% | 5.90% | |
| 70Outperform | TWD 10.47B | 21.08 | ― | 2.27% | -13.42% | 12.83% | |
| 62Neutral | TWD 10.68B | 9.60 | ― | 6.52% | -3.82% | 2.23% | |
| 56Neutral | TWD 9.20B | 16.65 | ― | 5.46% | 4.00% | -25.06% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 44Neutral | TWD 10.73B | 17.60 | ― | 2.54% | -1.04% | 480.86% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1203 | Ve Wong Corporation | 44.05 | 5.29 | 13.66% | |
| TW:1264 | Tehmag Foods Corp. | 241.00 | -32.03 | -11.73% | |
| TW:1707 | Grape King Bio Ltd. | 79.30 | -42.79 | -35.05% | |
| TW:2908 | Test Rite International Co., Ltd. | 21.65 | 1.97 | 9.99% | |
| TW:6469 | Great Tree Pharmacy Co., Ltd. | 57.80 | -36.31 | -38.59% | |
| TW:8436 | TCI Co., Ltd. | 92.20 | -23.50 | -20.31% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 10, 2026
